SE440078B - Forfarande for framstellning av 2-hydroximetyl-3-hydroxi-6-(1-hydroxi-2-t-butylaminoetyl)-pyridin genom hydrogenolys av dess bensylidenacetal - Google Patents

Forfarande for framstellning av 2-hydroximetyl-3-hydroxi-6-(1-hydroxi-2-t-butylaminoetyl)-pyridin genom hydrogenolys av dess bensylidenacetal

Info

Publication number
SE440078B
SE440078B SE7804955A SE7804955A SE440078B SE 440078 B SE440078 B SE 440078B SE 7804955 A SE7804955 A SE 7804955A SE 7804955 A SE7804955 A SE 7804955A SE 440078 B SE440078 B SE 440078B
Authority
SE
Sweden
Prior art keywords
water
hydroxy
hydrogenolysis
palladium
pirbuterol
Prior art date
Application number
SE7804955A
Other languages
English (en)
Swedish (sv)
Other versions
SE7804955L (sv
Inventor
S Nakanishi
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of SE7804955L publication Critical patent/SE7804955L/xx
Publication of SE440078B publication Critical patent/SE440078B/sv

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
SE7804955A 1977-05-02 1978-04-28 Forfarande for framstellning av 2-hydroximetyl-3-hydroxi-6-(1-hydroxi-2-t-butylaminoetyl)-pyridin genom hydrogenolys av dess bensylidenacetal SE440078B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US79281477A 1977-05-02 1977-05-02

Publications (2)

Publication Number Publication Date
SE7804955L SE7804955L (sv) 1978-11-03
SE440078B true SE440078B (sv) 1985-07-15

Family

ID=25158151

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7804955A SE440078B (sv) 1977-05-02 1978-04-28 Forfarande for framstellning av 2-hydroximetyl-3-hydroxi-6-(1-hydroxi-2-t-butylaminoetyl)-pyridin genom hydrogenolys av dess bensylidenacetal

Country Status (2)

Country Link
AT (1) AT363472B (de)
SE (1) SE440078B (de)

Also Published As

Publication number Publication date
ATA318778A (de) 1981-01-15
SE7804955L (sv) 1978-11-03
AT363472B (de) 1981-08-10

Similar Documents

Publication Publication Date Title
KR20200131241A (ko) 2종의 4-{[(2s)-2-{4-[5-클로로-2-(1h-1,2,3-트리아졸-1-일)페닐]-5-메톡시-2-옥소피리딘-1(2h)-일}부타노일]아미노}-2-플루오로벤즈아미드 유도체의 제조 방법
GB2271565A (en) Facile condensation of methylbenzoxazoles with aromatic aldehydes
JP2003513974A (ja) イミダゾリジノン系αv−インテグリン拮抗薬の製造方法および製造用中間体
KR100317907B1 (ko) 신규한 중간체, 이를 이용한 마크로라이드계 항생제의제조방법
US12116352B2 (en) Process for preparing 1-deoxy-1-methylamino-d-glucitol 2-(3,5-dichlorophenyl)-6-benzoxazolecarboxylate
CN106220624B (zh) 制备阿哌沙班n-1形式的方法
HU222121B1 (hu) Eljárás benzoesavszármazékok előállítására
CA1074322A (en) 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-t-butylaminoethyl) pyridine via hydrogenolysis of its benzylidene acetal
JPH02212475A (ja) 2―クロル―5―クロルメチルピリジンの製造法
HUP0200839A2 (en) Novel synthesis and crystallization of piperazine ring-containing compounds and pharmaceutical compositions containing them
EP2401253B1 (de) Verfahren zur herstellung von etoricoxib
US4031108A (en) 2-Hydroxymethyl-3-benzyloxypyridine-6-epoxyethane
EP0058071B1 (de) Verfahren und Zwischenverbindungen zur Herstellung von Pirbuterol
HU193780B (en) Process for producing 2-halogeno-6-methyl-ergol-9-ene derivatives and acid additional salts thereof
SE437159B (sv) Maleinsyrasalt av 2-fenyl-6-(1-hydroxi-2-t-butylaminoetyl)-4h-pyrido(3,2-d)-1,3-dioxin for anvendning sasom intermediat vid framstellning av 2-hydroximetyl-3-hydroxi-6-(1-hydroxi-2-t-butylaminoetyl)-pyridin
CN120590331A (zh) 一种(2s,6s)-2,6-二甲基-1-哌嗪羧酸叔丁酯的制备方法
NO802345L (no) Fremgangsmaate ved fremstilling av nye, halogenerte 15-hydroxy-e-homoeburnanderivater
JP6780958B2 (ja) 結晶構造を有する1−(3−カルボキシピリジル−2−)−2−フェニル−4−メチルピペラジン及びその製造方法
Morisawa et al. Modification at the 2-Position of 4-Deoxypyridoxol and α4-Norpyridoxol
TW491850B (en) Process for preparing etoposide
GB2173502A (en) New thiadiazole compounds and processes for their preparation
CA1066281A (en) Process for preparing maleate of 2-phenyl-6-(1-hydroxy-2-t-butylaminoethyl)-4h-pyrido-(3,2-d)-1,3-dioxin
WO2015177801A1 (en) Novel process for the preparation of a lactam-containing compound
HU193781B (en) Process for producing 10alpha-methoxy-6-methylergoline derivatives and acid additional salts thereof
JPH023799B2 (de)

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7804955-8

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7804955-8

Format of ref document f/p: F